๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effects of Ropivacaine Concentrations on Prolonged Labor Analgesia
NCT07007650Labor Analgesia, Prolonged, Ropivacaine, Concentration
Chengdu Jinjiang Maternity and Child Health Hospital
Not applicable
100
Chengdu
2025-06-14
Recruiting
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
NCT06707194Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)
Nanfang Hospital, Southern Medical University
Phase 4
340
Hefei, Chongqing, Guangzhou, Hohhot, Ganzhou
2025-06-14
Not yet open
Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
NCT06986018Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis
Peking University People's Hospital
Phase EARLY_PHASE1
12
Beijing
2025-06-14
Recruiting
Phase I Study of XTL6001 Injection in Healthy and Obese Subjects
NCT07205432Weight Management in Adult Patients With Obesity or Overweight
Shanghai Xitaili Biomedicine Technology co., Ltd.
Phase 1
80
Beijing
2025-06-13
Recruiting
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
NCT07112144Prevent Whooping Cough, Prevent Diphtheria, Prevent Tetanus
Changchun BCHT Biotechnology Co.
Phase 3
1,650
Wenshan Zhuang and Miao Autonomous Prefecture
2025-06-13
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
NCT06933472Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease), Dialysis
Alebund Pharmaceuticals
Phase 3
264
Beijing, Xiamen, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong, Wuxi
2025-06-13
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
NCT06951711Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb
Phase 3
274
Beijing, Wuhan, Changsha, Jining Shi, Tianjin
2025-06-13
Recruiting
Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial
NCT07662733Postoperative Sleep Disturbances, Chronic Post-surgical Pain
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2025-06-13
Recruiting
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
NCT06857487Acute Ischemic Stroke
Dongzhimen Hospital, Beijing
Phase 1/2
72
Beijing
2025-06-13
Recruiting
The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM
NCT07050381Arteriovenous Malformation of Central Nervous System, Aneurysm, Ruptured, Aneurysmatic Subarachnoid Haemorrhage, Aneurysm Cerebral
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2025-06-13
Recruiting
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
NCT06901466Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4
880
Beijing
2025-06-13
Recruiting
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
NCT07315191Henoch Schรถnlein Purpura Nephritis
Capital Institute of Pediatrics, China
Phase 4
116
Beijing
2025-06-13
Recruiting
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
NCT07327034Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd
Phase 2
141
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Guilin, Liuzhou, Nanning
2025-06-13
Recruiting
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
NCT07363967Solid Tumor Malignancies
Beijing StoneWise Technology Co., Ltd
Phase 1
60
Shanghai
2025-06-13
Recruiting
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
NCT06674252Lung Cancers
Peking University Cancer Hospital & Institute
Not applicable
174
Beijing
2025-06-13
Recruiting
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
NCT07010263Small Cell Lung Cancer
Akeso
Phase 3
560
Beijing, Beijin, Chongqing, Fuzhou, Longyan, Zhangzhou, Lanzhou, Jiangmen
2025-06-13
Active, closed
Study of ZG005 in Patients With Advanced Solid Tumors
NCT06927687Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2
50
Guangzhou
2025-06-13
Recruiting
Biomarkers Based EArly Diagnosis of STroke Subtype Cohort๏ผˆBio-EAST๏ผ‰
NCT07003477Stroke
Shanghai East Hospital
Observational
527
Shanghai
2025-06-12
Recruiting
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
NCT06975748Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 2
48
Jinan
2025-06-12
Recruiting
A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors
NCT06990698Advanced Solid Tumors
Zhuhai Fapon Biopharma Co., Ltd.
Phase 1
108
Wuhan, Taiyuan, Hangzhou
2025-06-12
Recruiting
Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
NCT06926751Solid Tumors, Children, Adolescent, Chemotherapy Induced Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
132
Beijing
2025-06-12
Recruiting
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
NCT07012772Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Phase 2
50
Hangzhou
2025-06-12
Active, closed
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
NCT07029555Rheumatoid Arthritis
Novartis Pharmaceuticals
Phase 1
57
Beijing
2025-06-12
Not yet open
Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia
NCT07012902Induction Anesthesia, Drug Interactions
Second Hospital of Shanxi Medical University
Phase EARLY_PHASE1
125
Taiyuan
2025-06-12
Recruiting
Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors
NCT07301801Malignant Tumors, SSTR2, PET
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
10
Wuhan
2025-06-12
Recruiting
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
NCT07051980Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Phase 2
50
Hangzhou
2025-06-12
Recruiting
Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
NCT06892145Systemic Lupus Erythematosus (SLE), Refractory
Chongqing Precision Biotech Co., Ltd
Phase 1
12
Hefei, Hangzhou
2025-06-12
Recruiting
PIMS vs PGT-A in Infertile PCOS Patients
NCT06887881PGT-A, PCOS, PIMS
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
766
Zhongshan
2025-06-12
Recruiting
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT07376707CRC (Colorectal Cancer), Melanoma (Skin Cancer), HCC - Hepatocellular Carcinoma, NSCLC (Non-small Cell Lung Cancer)
Hefei TG ImmunoPharma Co., Ltd.
Phase 1
194
Shanghai
2025-06-12
Recruiting
Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia
NCT07028190Insomnia, Digestive Endoscopy
Beijing Tiantan Hospital
Observational
840
Beijing
2025-06-12
Not yet open
Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
NCT07024394Neurofibromatosis 1, Plexiform Neurofibroma, NF1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1/2
65
Shanghai
2025-06-12
Recruiting
NWRD09 for HPV-16 Related Cervical HSIL
NCT07047989High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd.
Phase 1
9
Beijing
2025-06-12
Recruiting
Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia
NCT07028177Insomnia, Digestive Endoscopy
Beijing Tiantan Hospital
Observational
840
Beijing
2025-06-12
Recruiting
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMIโ‰ฅ28 kg/m2
NCT06931028Sleep Apnea, Obstructive, Obesity
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
260
Beijing
2025-06-12
Recruiting
A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients
NCT06990464Advanced Solid Tumors
Shanghai Institute Of Biological Products
Phase 1
156
Fuzhou
2025-06-11
Recruiting
Leucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
NCT07359989Rectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
33
Hangzhou
2025-06-11
Recruiting
Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT07014202Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
224
Beijing
2025-06-11
Recruiting
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
NCT06953999Pancreatic Cancer
Akeso
Phase 3
999
Harbin, Shanghai, Hangzhou
2025-06-11
Recruiting
HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors
NCT06822998Advanced Solid Tumors
HighField Biopharmaceuticals Corporation
Phase EARLY_PHASE1
10
Chengdu
2025-06-11
Recruiting
A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer
NCT07653893Central Nervous System (CNS) Metastases, Breast Cancer
Fudan University
Observational
60
Shanghai
2025-06-11
By invitation
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
NCT07074704Negative Symptoms in Schizophrenia, Cognition Function
Tongji University
Not applicable
60
Shanghai
2025-06-11
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
NCT06783647Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd
Phase 2
250
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Guilin, Nanning, Harbin
2025-06-11
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines
Phase 3
630
Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Shijiazhuang, Harbin
2025-06-11
Recruiting
FIH Study of PFLotus in Persistent Atrial Fibrillation
NCT07301190Persistent Atrial Fibrillation
The Third People's Hospital of Chengdu
Not applicable
40
Chengdu
2025-06-11
Recruiting
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
NCT07021534Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
Zhejiang University
Phase 1
12
Hangzhou
2025-06-10
Recruiting
A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation
NCT06908434Solid Tumors Harboring a TP53 Y220C Mutation
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
82
Shanghai
2025-06-10
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568Endometrial Cancer
BioNTech SE
Phase 3
480
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Shantou
2025-06-10
Recruiting
A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China
NCT06931691Paroxysmal Nocturnal Hemoglobinuria
Novartis Pharmaceuticals
Observational
80
Hefei, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nantong, Nanchang, Changchun
2025-06-10
Recruiting
Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin
NCT07106957Erythematous Telangiectatic Rosacea
Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Not applicable
72
Beijing
2025-06-10
Recruiting
Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial
NCT06791551Cardiac Surgery
China National Center for Cardiovascular Diseases
Not applicable
200
Beijing
2025-06-10
Recruiting
Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma
NCT07014150Hepatocellular Carcinoma Resectable
Peking Union Medical College Hospital
Phase 2
33
Beijing
2025-06-10
Recruiting
A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer
NCT06978114Advanced Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
46
Shanghai
2025-06-10
Not yet open
The Influence of Central Sensitization in Endometriosis Disease
NCT07014761Endometriosis, Adenomatosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
200
Guangzhou
2025-06-10
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury
NCT06954740Acute Kidney Injury
Chinese PLA General Hospital
Phase 2
50
Beijing
2025-06-10
Recruiting
Protein Supplementation Intervention on Body Weight
NCT06989203Obesity, Weight Loss, Protein Supplementation
Chinese Academy of Sciences
Not applicable
140
Hangzhou
2025-06-10
Not yet open
Safety and Effectiveness of Unilateral MR-Guided Focused Ultrasound Thalamotomy for Essential Tremor
NCT07006740Essential Tremor
meishanshan
Observational
100
Beijing
2025-06-10
Recruiting
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06972641AML, MDS
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
Lactobacillus Plantarum and Hormonal Regulation in Obese Women
NCT06987279Obesity, Women
Wecare Probiotics Co., Ltd.
Not applicable
100
Zhengzhou
2025-06-10
Not yet open
Telitacicept for the Treatment of Refractory RA
NCT07008196Rheumatoid Arthritis (RA)
Chinese SLE Treatment And Research Group
Phase 4
30
Beijing
2025-06-10
Recruiting
A Dose-Expansion Trial of Intravenous HNF4ฮฑ srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394Colorectal Cancer Metastatic, Colorectal Cancer Recurrent, Colorectal Cancer Stage IV
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
20
Shanghai
2025-06-10
Recruiting
Probiotic Intervention on Body Weight
NCT06989177Obesity, Homeostasis, Weight Loss, Probiotic Intervention
Chinese Academy of Sciences
Not applicable
140
Hangzhou
2025-06-10
Not yet open
Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)
NCT06969703Fungal Disease
Peking University First Hospital
Observational
30
Beijing
2025-06-10
Recruiting
Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases
NCT06978231Pancreaticobiilary Diseases
Qilu Hospital of Shandong University
Not applicable
214
Jinan
2025-06-10
Not yet open
To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH
NCT07016633Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD
Phase 1/2
40
Changchun
2025-06-10
Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT06993844Advanced Solid Tumors, Advanced Breast Cancer
Ensem Therapeutics
Phase 1/2
233
Beijing, Fuzhou, Guangzhou, Shandong, Shanghai
2025-06-10
Active, closed
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
NCT07010120HNSCC, Lysogenic HSV Virus, Neoadjuvant Therapy, Immunotherapy
West China Hospital
Phase 1/2
29
Chengdu
2025-06-10
Recruiting
AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)
NCT07062380Hepatecellular Carcinoma, Hepatectomy
Tongji Hospital
Observational
353
Wuhan
2025-06-10
Recruiting
Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease
NCT06969807Diabetic Kidney Disease (DKD)
Chinese PLA General Hospital
Phase 2
120
Beijing
2025-06-09
Recruiting
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
NCT06933069Solid Malignancies
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
55
Shanghai
2025-06-09
Active, closed
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
NCT06956235Hidradenitis Suppurativa
Merck Sharp & Dohme LLC
Phase 2
149
Guangzhou, Changsha, Changchun, Shanghai, รœrรผmqi, Hangzhou
2025-06-09
Recruiting
A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis
NCT07034157Coronary Artery Disease, Carotid Artery Stenosis, Cerebrovascular Disorders
Beijing Anzhen Hospital
Observational
1,000
Beijing
2025-06-09
Recruiting
SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
NCT07051603Uncontrolled Hypertension
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
82
Guangzhou
2025-06-09
Active, closed
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
NCT06993116Advanced Solid Tumor
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
15
Fuzhou, Changsha
2025-06-09
Recruiting
The AIRTIVITYโ„ข Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892Bronchiectasis
Boehringer Ingelheim
Phase 3
1,755
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Guiyang, Hangzhou, Hefei
2025-06-09
Recruiting
The Effect of Oral Oxytocin and Atosiban on Social Attention
NCT07093060Healhty
University of Electronic Science and Technology of China
Phase EARLY_PHASE1
250
Chengdu
2025-06-09
Recruiting
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06907615Non Small Cell Lung Cancer
Shanghai Henlius Biotech
Phase 2
243
Beijing
2025-06-09
Recruiting
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
NCT07016802Safety, Tolerability, Adult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
64
Beijing
2025-06-09
Recruiting
A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations
NCT06947811EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
Sun Yat-sen University
Phase 1/2
71
Guangzhou
2025-06-09
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
NCT06808984Agitation, Alzheimer Disease
Celgene
Phase 2
120
Hefei, Beijing, Wuhan, Nanjing, Shanghai Shi, Hangzhou
2025-06-09
Recruiting
Temporal Interference for Essential Tremor
NCT07016425Essential Tremor
Liankun_Ren
Not applicable
10
Beijing
2025-06-09
Recruiting
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
NCT07026149Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2
30
Shanghai
2025-06-08
Recruiting
External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia
NCT06966245Mastalgia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
190
Guangzhou
2025-06-08
Recruiting
Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China
NCT07255105CLABSI - Central Line Associated Bloodstream Infection
Jianfeng Xie
Observational
1,846
Nanjing
2025-06-08
Recruiting
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
NCT07069569Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
200
Beijing, Chongqing, Fuzhou, Guangzhou, Shenzhen, Zunyi, Wuhan, Changchun
2025-06-08
Recruiting
A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults
NCT07149831Prostate Cancer
Sinotau Pharmaceutical Group
Phase 1
6
Beijing
2025-06-07
Not yet open
A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss
NCT07012746Age Related Hearing Loss, Deafness
Yilai Shu
Not applicable
60
Shanghai
2025-06-07
Recruiting
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06793917Gastric Cancer
Fujian Cancer Hospital
Phase 3
269
Fuzhou
2025-06-07
Not yet open
Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus
NCT06966830Epilepsy, Status Epilepticus
Second Affiliated Hospital of Guangzhou Medical University
Observational
100
Guangzhou
2025-06-06
Recruiting
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease
NCT06978920Parkinson Disease
Nuwacell Biotechnologies Co., Ltd.
Phase 1
48
Hefei
2025-06-06
Active, closed
Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang
NCT07624461Rabies Post-exposure Prophylaxis, Rabies
Synermore Biologics (Suzhou) Co., Ltd.
Observational
80
Nanyang
2025-06-06
Recruiting
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
NCT06946927NSCLC (Advanced Non-small Cell Lung Cancer)
Jemincare
Phase 1
72
Guangzhou
2025-06-06
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Recruiting
Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
NCT07257471Lung Cancer (NSCLC)
Beijing Haidian Hospital
Observational
30
Beijing
2025-06-06
Active, closed
Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques
NCT06416813Acute Coronary Syndrome
Yong He
Not applicable
140
Sichuan Chengdu
2025-06-06
Recruiting
A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT07446491Thrombocytopenia Associated With Chronic Liver Disease
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1/2
54
Beijing, Chongqing, Guangzhou, Zhengzhou, Zhenjiang, Changchun, Chaozhou, Qingdao
2025-06-06
Recruiting
First-in-Human Single and Multiple Dose of KLA578-1 for Injection
NCT07143318Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
48
Changsha
2025-06-05
Active, closed
Shared Medical Appointment for COPD Patients (SMA-COPD)
NCT07128745Chronic Obstructive Pulmonary Disease, COPD
Peking University Third Hospital
Not applicable
280
Beijing
2025-06-05
Recruiting
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
NCT06907329Immunosenescence, Metabolism
Qing Su
Not applicable
126
Shanghai
2025-06-05
Recruiting
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
NCT06914440Breast Cancer
Xijing Hospital
Phase 2
27
Xi'an
2025-06-05
Recruiting
Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
NCT07272382Esophageal Neoplasms
Fudan University
Not applicable
142
Shanghai
2025-06-05
Rows per page Showing 7601–7700 of 19052
Previous 75 76 77 78 79 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=77

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.